Cytokinetics (CYTK) Tops Q4 EPS Views; Offers FY15 Outlook

Go back to Cytokinetics (CYTK) Tops Q4 EPS Views; Offers FY15 Outlook

Form 8-K CYTOKINETICS INC For: Feb 12

February 12, 2015 4:08 PM EST
 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

      Date of Report (Date of Earliest Event Reported):   February 12,... More

Form 8-K CYTOKINETICS INC For: Feb 09

February 10, 2015 4:39 PM EST

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): February 9,... More